BioReliance
 
Home About Us Services What's Your Product? Resources Careers Contact Us
  Home
 

News

Darryl L. Goss joins Bioreliance Darryl L. Goss has been appointed Vice President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly formed Business Unit.
Click here to read the press release.

 

   

The safety testing of cell substrates for the presence of viruses in biotechnology products is an important issue and is required by regulatory agencies world-wide.

In Vivo Assays for the Presence of Inapparent Viruses

Back to In Vivo Testing

As a minimum, the in vivo assays for inapparent viruses should be performed on master cell banks and the cells at the limit of in vitro cell age, although testing during other stages of biological product development can also be appropriate. The in vivo assays for the presence of adventitious viruses use a number of different animal systems to maximize the probability of detecting a virus in a test article. Those assays, however, are not designed to identify the viral contaminants once detected. Therefore, various animal systems are used. When an adventitious viral agent is detected, BioReliance consults with the client and a confirmatory procedure is performed.

 
for further information and enquiries please contact: info@bioreliance.com